Cargando…

Immune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery

SIMPLE SUMMARY: Chemoimmunotherapy combinations have transformed the treatment landscape for patients with triple-negative breast cancer (TNBC). However, the discovery of immune-related biomarkers is needed to optimally identify patients requiring the addition of immune-checkpoint inhibitors (ICIs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kholod, Olha, Basket, William I., Mitchem, Jonathan B., Kaifi, Jussuf T., Hammer, Richard D., Papageorgiou, Christos N., Shyu, Chi-Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735620/ https://www.ncbi.nlm.nih.gov/pubmed/36497286 http://dx.doi.org/10.3390/cancers14235806

Ejemplares similares

Identification of Immuno-Targeted Combination Therapies Using Explanatory Subgroup Discovery for Cancer Patients with EGFR Wild-Type Gene
por: Kholod, Olha, et al.
Publicado: (2022)

Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer
por: Al-Taie, Zainab, et al.
Publicado: (2021)

Exploratory Data Mining for Subgroup Cohort Discoveries and Prioritization
por: Liu, Danlu, et al.
Publicado: (2020)

TBX21 Methylation as a Potential Regulator of Immune Suppression in CMS1 Subtype Colorectal Cancer
por: Shen, Yuanyuan, et al.
Publicado: (2022)

Current and Prospective Methods for Assessing Anti-Tumor Immunity in Colorectal Cancer
por: Nussbaum, Yulia I., et al.
Publicado: (2021)

Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer
por: Liu, Siyan, et al.
Publicado: (2022)

Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer
por: Gao, Tong, et al.
Publicado: (2023)

Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model
por: Dong, Hang, et al.
Publicado: (2023)

The 3′UTR signature defines a highly metastatic subgroup of triple-negative breast cancer
por: Wang, Lei, et al.
Publicado: (2016)

Current and Future Role of Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: Which Way to Go Forward
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses
por: Suvilesh, Kanve N., et al.
Publicado: (2022)

Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer
por: Chun, Brie, et al.
Publicado: (2022)

(18)F-FDG PET/CT total lesion glycolysis is associated with circulating tumor cell counts in patients with stage I to IIIA non-small cell lung cancer
por: Avella, Diego M., et al.
Publicado: (2020)

Co-delivery of gemcitabine and paclitaxel plus NanoCpG empowers chemoimmunotherapy of postoperative “cold” triple-negative breast cancer
por: Guo, Beibei, et al.
Publicado: (2023)

Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy
por: Smith, Margaret R., et al.
Publicado: (2023)

BRCA1‐like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential
por: Severson, Tesa M., et al.
Publicado: (2015)

Tumor-Cell–Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer
por: Manjunath, Yariswamy, et al.
Publicado: (2020)

Metabolomics-Based Discovery of Molecular Signatures for Triple Negative Breast Cancer in Asian Female Population
por: Li, Lixian, et al.
Publicado: (2020)

Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer
por: Bender, R. Joseph, et al.
Publicado: (2013)

Artificial Intelligence-Driven Structurization of Diagnostic Information in Free-Text Pathology Reports
por: Giannaris, Pericles S., et al.
Publicado: (2020)

REDESIGN: RDF–based Differential Signaling Framework for Precision Medicine Analytics
por: Al–Taie, Zainab, et al.
Publicado: (2018)

Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia
por: Santoro, Marco, et al.
Publicado: (2022)

Clog-free high-throughput microfluidic cell isolation with multifunctional microposts
por: Venugopal, Dilip, et al.
Publicado: (2021)

MAPK signaling regulates the efficacy of chemoimmunotherapy
por: Ghiringhelli, François
Publicado: (2022)

Omental infarction in the postpartum period: a case report and a review of the literature
por: Tachezy, Michael, et al.
Publicado: (2010)

Author Correction: RNA cargos in extracellular vesicles derived from blood serum in pancreas associated conditions
por: Kumar, Senthil R., et al.
Publicado: (2020)

RNA cargos in extracellular vesicles derived from blood serum in pancreas associated conditions
por: Kumar, Senthil R., et al.
Publicado: (2020)

Computerized tomography-Guided Microwave Ablation of Patients with Stage I Non-small Cell Lung Cancers: A Single-Institution Retrospective Study
por: Nance, Michael, et al.
Publicado: (2021)

Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma
por: Dittrich, Katherine, et al.
Publicado: (2023)

CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer
por: Craven, Kelly E., et al.
Publicado: (2021)

Single Circulating-Tumor-Cell-Targeted Sequencing to Identify Somatic Variants in Liquid Biopsies in Non-Small-Cell Lung Cancer Patients
por: Barbirou, Mouadh, et al.
Publicado: (2022)

Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer
por: Shen, Yuanyuan, et al.
Publicado: (2020)

Chemoimmunotherapy as long-term maintenance therapy for cancer
por: Egilmez, Nejat K., et al.
Publicado: (2012)

Complete response of metastatic gastric cancer to chemoimmunotherapy
por: Ina, Kenji, et al.
Publicado: (2017)

Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy
por: Wang, Tianqi, et al.
Publicado: (2021)

Targeted delivery of liposomal chemoimmunotherapy for cancer treatment
por: Liu, Yusheng, et al.
Publicado: (2022)

DISGROU: an algorithm for discontinuous subgroup discovery
por: Eugenie, Reynald, et al.
Publicado: (2021)

Distinct microbiological signatures associated with triple negative breast cancer
por: Banerjee, Sagarika, et al.
Publicado: (2015)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c7b4qes44ds7vebjbgpm4pof30